{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:00:52Z","timestamp":1778886052867,"version":"3.51.4"},"reference-count":65,"publisher":"American Society of Hematology","issue":"22","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Previous studies have reported elevated von Willebrand factor (VWF) levels in patients with sickle cell disease (SCD) and demonstrated a key role for the VWF-ADAMTS13 axis in the pathobiology of SCD vaso-occlusion. Although blood transfusion is the gold standard for stroke prevention in SCD, the biological mechanisms underpinning its improved efficacy compared with hydroxycarbamide are not fully understood. We hypothesized that the improved efficacy of blood transfusion might relate to differences in VWF\u2013ADAMTS13 axis dysfunction. In total, 180 children with a confirmed diagnosis of SCD (hemoglobin SS) on hydroxycarbamide (n = 96) or blood transfusion (n = 84) were included. Despite disease-modifying treatment, plasma VWF and VWF propeptide were elevated in a significant proportion of children with SCD (33% and 47%, respectively). Crucially, all VWF parameters were significantly higher in the hydroxycarbamide compared with the blood transfusion cohort (P &amp;lt; .05). Additionally, increased levels of other Weibel-Palade body\u2013stored proteins, including factor VIII (FVIII), angiopoietin-2, and osteoprotegerin were observed, indicated ongoing endothelial cell activation. Children treated with hydroxycarbamide also had higher FVIII activity and enhanced thrombin generation compared with those in the blood transfusion cohort (P &amp;lt; .001). Finally, hemolysis markers strongly correlated with VWF levels (P &amp;lt; .001) and were significantly reduced in the blood transfusion cohort (P &amp;lt; .001). Cumulatively, to our knowledge, our findings demonstrate for the first time that despite\u00a0treatment, ongoing dysfunction of the VWF\u2013ADAMTS13 axis is present in a significant subgroup of pediatric patients with SCD, especially those treated with hydroxycarbamide.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010824","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T17:20:07Z","timestamp":1696008007000},"page":"6974-6989","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["VWF\u2013ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion"],"prefix":"10.1182","volume":"7","author":[{"given":"Helen","family":"Fogarty","sequence":"first","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"},{"name":"2Department of Haematology, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"},{"name":"3National Children\u2019s Research Centre, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azaz","family":"Ahmad","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdows","family":"Atiq","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dearbhla","family":"Doherty","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soracha","family":"Ward","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellie","family":"Karampini","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling","family":"Rehill","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Leon","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-0644","authenticated-orcid":false,"given":"Ciara","family":"Byrne","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosena","family":"Geoghegan","sequence":"additional","affiliation":[{"name":"2Department of Haematology, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Conroy","sequence":"additional","affiliation":[{"name":"2Department of Haematology, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-1718","authenticated-orcid":false,"given":"Mary","family":"Byrne","sequence":"additional","affiliation":[{"name":"4National Coagulation Centre, St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[{"name":"5Department of Haemostaseology, MVZ Medilys Laborgesellschaft mbH, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Schneppenheim","sequence":"additional","affiliation":[{"name":"5Department of Haemostaseology, MVZ Medilys Laborgesellschaft mbH, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"Sheehan","sequence":"additional","affiliation":[{"name":"6Department of Haematology, St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Ngwenya","sequence":"additional","affiliation":[{"name":"6Department of Haematology, St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-6788","authenticated-orcid":false,"given":"Ross I.","family":"Baker","sequence":"additional","affiliation":[{"name":"7Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, WA, Australia"},{"name":"8Irish-Australian Blood Collaborative Network, Dublin, Ireland and Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-4077","authenticated-orcid":false,"given":"Roger J. S.","family":"Preston","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"},{"name":"3National Children\u2019s Research Centre, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Tuohy","sequence":"additional","affiliation":[{"name":"6Department of Haematology, St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrina","family":"McMahon","sequence":"additional","affiliation":[{"name":"2Department of Haematology, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"},{"name":"3National Children\u2019s Research Centre, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-3313","authenticated-orcid":false,"given":"James S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"},{"name":"3National Children\u2019s Research Centre, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"},{"name":"4National Coagulation Centre, St. James\u2019s Hospital, Dublin, Ireland"},{"name":"8Irish-Australian Blood Collaborative Network, Dublin, Ireland and Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"issue":"23","key":"2023112812511415000_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"2023112812511415000_bib2","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2023112812511415000_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2023112812511415000_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/mic.11.2.167.177","article-title":"Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion","volume":"11","author":"Frenette","year":"2004","journal-title":"Microcirculation"},{"issue":"2","key":"2023112812511415000_bib5","first-page":"101","article-title":"The not-so-simple process of sickle cell vasoocclusion","volume":"11","author":"Embury","year":"2004","journal-title":"Microcirculation"},{"issue":"9","key":"2023112812511415000_bib6","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1073\/pnas.86.9.3356","article-title":"Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications","volume":"86","author":"Kaul","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2023112812511415000_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2023112812511415000_bib8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2023112812511415000_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMc1616060","article-title":"Von Willebrand\u2019s disease","volume":"376","author":"Leebeek","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2023112812511415000_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"2023112812511415000_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hae.14078","article-title":"Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia","volume":"26","author":"Turecek","year":"2020","journal-title":"Haemophilia"},{"issue":"12","key":"2023112812511415000_bib12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2006-03-010322","article-title":"P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor","volume":"108","author":"Pendu","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2023112812511415000_bib13","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","article-title":"Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in\u00a0vivo","volume":"112","author":"van Schooten","year":"2008","journal-title":"Blood"},{"issue":"15","key":"2023112812511415000_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2016-04-709436","article-title":"N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance","volume":"128","author":"Chion","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2023112812511415000_bib15","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1038\/s41467-022-33796-7","article-title":"von Willebrand factor links primary hemostasis to innate immunity","volume":"13","author":"Drakeford","year":"2022","journal-title":"Nat Commun"},{"issue":"22","key":"2023112812511415000_bib16","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2010-03-276311","article-title":"von Willebrand factor promotes leukocyte extravasation","volume":"116","author":"Petri","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2023112812511415000_bib17","doi-asserted-by":"crossref","first-page":"e78801","DOI":"10.1371\/journal.pone.0078801","article-title":"Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy","volume":"8","author":"Colombatti","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2023112812511415000_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bcmd.2010.10.016","article-title":"Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis","volume":"46","author":"Nur","year":"2011","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"2023112812511415000_bib19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.thromres.2013.10.006","article-title":"Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease","volume":"132","author":"van der Land","year":"2013","journal-title":"Thromb Res"},{"issue":"2","key":"2023112812511415000_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12185-013-1392-y","article-title":"Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease","volume":"98","author":"Hatzipantelis","year":"2013","journal-title":"Int J Hematol"},{"issue":"7","key":"2023112812511415000_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ajh.20653","article-title":"ADAMTS13 activity in sickle cell disease","volume":"81","author":"Schnog","year":"2006","journal-title":"Am J Hematol"},{"issue":"11","key":"2023112812511415000_bib22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","article-title":"Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease","volume":"94","author":"van Beers","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"2023112812511415000_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/rth2.12460","article-title":"ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease","volume":"5","author":"Demagny","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"13","key":"2023112812511415000_bib24","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2010-08-302539","article-title":"The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2023112812511415000_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jth.13728","article-title":"Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state","volume":"15","author":"Sins","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2023112812511415000_bib26","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V81.9.2429.2429","article-title":"Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion","volume":"81","author":"Kaul","year":"1993","journal-title":"Blood"},{"issue":"1","key":"2023112812511415000_bib27","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1038\/s41598-018-28961-2","article-title":"Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy","volume":"8","author":"Nicolay","year":"2018","journal-title":"Sci Rep"},{"issue":"34","key":"2023112812511415000_bib28","doi-asserted-by":"crossref","first-page":"e2207592119","DOI":"10.1073\/pnas.2207592119","article-title":"Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease","volume":"119","author":"Shi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2023112812511415000_bib29","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3324\/haematol.2021.280233","article-title":"Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease","volume":"107","author":"Rossato","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"2023112812511415000_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtha.2022.10.024","article-title":"Targeting the von Willebrand factor-ADAMTS-13 axis in sickle cell disease","volume":"21","author":"Ellsworth","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2023112812511415000_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023112812511415000_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.14346","article-title":"Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"2023112812511415000_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2023112812511415000_bib34","doi-asserted-by":"crossref","first-page":"e1000349","DOI":"10.1371\/journal.ppat.1000349","article-title":"Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition","volume":"5","author":"Larkin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"2023112812511415000_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Budde","year":"1990","journal-title":"Thromb Haemost"},{"issue":"2","key":"2023112812511415000_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11845-021-02588-1","article-title":"Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease","volume":"191","author":"Fogarty","year":"2022","journal-title":"Ir J Med Sci"},{"issue":"4","key":"2023112812511415000_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.17273","article-title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation","volume":"192","author":"Ward","year":"2021","journal-title":"Br J Haematol"},{"issue":"19","key":"2023112812511415000_bib38","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2015-11-636464","article-title":"Emerging roles for hemostatic dysfunction in malaria pathogenesis","volume":"127","author":"O'Sullivan","year":"2016","journal-title":"Blood"},{"issue":"15","key":"2023112812511415000_bib39","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2023112812511415000_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2023112812511415000_bib41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjh.16553","article-title":"Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor","volume":"190","author":"Nazy","year":"2020","journal-title":"Br J Haematol"},{"issue":"10","key":"2023112812511415000_bib42","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/jth.15830","article-title":"Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction","volume":"20","author":"Fogarty","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2023112812511415000_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance - biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"issue":"1-2","key":"2023112812511415000_bib44","first-page":"1","article-title":"Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism","volume":"47","author":"O'Donnell","year":"2001","journal-title":"Clin Lab"},{"key":"2023112812511415000_bib45","doi-asserted-by":"crossref","first-page":"561917","DOI":"10.3389\/fimmu.2020.561917","article-title":"The worst things in life are free: the role of free heme in sickle cell disease","volume":"11","author":"Gbotosho","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"2023112812511415000_bib46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"issue":"10","key":"2023112812511415000_bib47","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.13416","article-title":"Thrombin generation and cell-dependent hypercoagulability in sickle cell disease","volume":"14","author":"Whelihan","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2023112812511415000_bib48","doi-asserted-by":"crossref","first-page":"e0173077","DOI":"10.1371\/journal.pone.0173077","article-title":"Platelet-independent adhesion of calcium-loaded erythrocytes to von Willebrand factor","volume":"12","author":"Smeets","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"2023112812511415000_bib49","first-page":"105","article-title":"Thrombotic thrombocytopenic purpura: understanding a disease no longer rare","volume":"316","author":"Moake","year":"1998","journal-title":"Am J Med Sci"},{"issue":"8","key":"2023112812511415000_bib50","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.15409","article-title":"ADAMTS13 regulation of VWF multimer distribution in severe COVID-19","volume":"19","author":"Ward","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2023112812511415000_bib51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.14322","article-title":"Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit","volume":"17","author":"Schillemans","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2023112812511415000_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","article-title":"von Willebrand factor regulation of blood vessel formation","volume":"132","author":"Randi","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2023112812511415000_bib53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cardiores.2007.07.017","article-title":"Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2","volume":"76","author":"Mangan","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"9","key":"2023112812511415000_bib54","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1538-7836.2007.02681.x","article-title":"Characterization of the interaction between von Willebrand factor and osteoprotegerin","volume":"5","author":"Shahbazi","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"2023112812511415000_bib55","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jtha.2023.03.027","article-title":"von Willebrand factor binds to angiopoietin-2 within endothelial cells and after release from Weibel-Palade bodies","volume":"21","author":"Mobayen","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"14","key":"2023112812511415000_bib56","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2017-12-819870","article-title":"HO-1(hi) patrolling monocytes protect against vaso-occlusion in sickle cell disease","volume":"131","author":"Liu","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023112812511415000_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(00)01609-6","article-title":"Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation","volume":"22","author":"Wagener","year":"2001","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"2023112812511415000_bib58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"24","key":"2023112812511415000_bib59","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2023112812511415000_bib60","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3324\/haematol.2019.239350","article-title":"The molecular basis for the prothrombotic state in sickle cell disease","volume":"105","author":"Shet","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"2023112812511415000_bib61","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease","volume":"12","author":"Naik","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2023112812511415000_bib62","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2023112812511415000_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"issue":"7","key":"2023112812511415000_bib64","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jth.13717","article-title":"Prothrombotic aspects of sickle cell disease","volume":"15","author":"Sparkenbaugh","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2023112812511415000_bib65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","article-title":"Elevated factor VIII levels and risk of venous thrombosis","volume":"157","author":"Jenkins","year":"2012","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/22\/6974\/2110614\/blooda_adv-2023-010824-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/22\/6974\/2110614\/blooda_adv-2023-010824-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:52:20Z","timestamp":1701175940000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/22\/6974\/498170\/VWF-ADAMTS13-axis-dysfunction-in-children-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":65,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010824","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}